Loading viewer...
investor_presentation
Format: PDF investor_presentation
Sosei Heptares announced the acquisition of Idorsia's operations in Japan and APAC regions (excluding China) in July 2023. The deal combines the company's world-leading GPCR drug discovery platform with Idorsia's clinical development capabilities and high-margin pharmaceutical sales business. The acquisition advances Sosei's mission to deliver life-changing medicines to patients in Japan and APAC markets.
Simmons First National acquisition of Spirit of Texas Bancshares 2021
investor_presentationinvestor_presentation
23 Pages
Simmons First National Corporation
investor_presentation
eGain
FS Credit Opportunities Corp 2022 Investor Presentation
investor_presentationinvestor_presentation
26 Pages
FS Credit Opportunities Corp.